Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-017817
Filing Date
2016-04-08
Accepted
2016-04-08 17:00:53
Documents
1
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2770
  Complete submission text file 0000899243-16-017817.txt   3995
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
GILMAN STEVEN C (Reporting) CIK: 0001379970 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30929 | Film No.: 161563294